This study is for people with atopic dermatitis (AtD), a skin condition that causes itchy, red, and swollen skin. The study looks at the long-term safety and how well a new drug called GSK1070806 works. This study is only for those who were part of an earlier study named Phase 2b. Participants must be able to visit the doctor, use electronic devices, and answer questions. Women must not be pregnant or breastfeeding and if of childbearing potential, use effective birth control.
Things to Consider:
- The study is long-term, requiring regular doctor visits.
- Participants must have finished the earlier Phase 2b study.
- If you had problems with the study drug before, you cannot participate.
How understandable was the trial content above?
Hard to understand
Easy to understand